Publications by authors named "J J Strange"
Background: Bacteraemia and infective endocarditis (IE) are rare but severe complications of transcatheter aortic valve implantation (TAVI). Limited data exist on the incidence and microbiological profile of early bacteraemia in this population. This study aimed to evaluate the 6-month incidence of bacteraemia, IE and associated mortality following TAVI.
View Article and Find Full Text PDFA chicken protein hydrogel (HG) was enzymatically prepared and blended with a carnauba wax-based oleogel (OG) to form bigels (BG) in ratios of 50:50 to 90:10. These systems were infused with thyme essential oil (TEO) at 0.5 %, 1 %, and 2 % v/v to harness its antioxidant properties.
View Article and Find Full Text PDFBackground: Survival after transcatheter aortic valve replacement (TAVR) has markedly increased. Thus, other comorbidities will intersect patient trajectories and challenge follow-up.
Objectives: The aim of this study was to describe patient characteristics and hospitalizations at end of life to further improve the quality of life for patients undergoing TAVR.
Background: Despite improved survival, hospitalization is still common among patients with heart failure (HF).
Objective: This study aimed to examine temporal trends in infection-related hospitalization among HF patients and compare it to temporal trends in the risk of HF hospitalization and death.
Methods: Using Danish nationwide registers, we included all patients aged 18 to 100 years, with HF diagnosed between January 1, 1997 and December 31, 2017, resulting in a total population of 147.
Safety and Effectiveness of a Novel Microcatheter in Coronary Chronic Total Occlusions-The BIOMICS Study.
J Soc Cardiovasc Angiogr Interv
July 2024
Article Synopsis
- Chronic total occlusion (CTO) in coronary arteries poses significant challenges during percutaneous coronary interventions (PCI), often requiring advanced methods and tools like microcatheters.
- The BIOMICS study tested a new microcatheter (BioMC) in 100 patients with ischemic symptoms undergoing CTO-PCI, focusing on its ability to successfully facilitate guide wire placement and monitoring for safety issues like cardiac death or myocardial infarction.
- Results showed a 75% success rate in achieving the primary efficacy goal and only 2% incidence of severe safety events, indicating that the new microcatheter is both effective and safe in treating CTO.